Loading...

Chinese Journal of Blood Purification

    12 January 2019, Volume 18 Issue 01 Previous Issue    Next Issue
    Changes of abdominal aortic calcification and bone metabolism after parathyroidectomy in maintenance hemodialysis patients
    2019, 18 (01):  1-7.  doi: 10.3969/j.issn.1671-4091.2019.01.001
    Abstract ( 462 )   PDF (492KB) ( 720 )  
    【Abstract】Objective To investigate the changes of cardiovascular calcification and bone metabolism and their related factors after parathyroidectomy (PTX) in maintenance hemodialysis (MHD) patients. Methods Twelve MHD patients undergoing PTX operation and follow-up for one year were retrospectively analyzed. Intact parathyroid hormone (iPTH) of these patients was <600pg/ml after PTX for one week, and recurrence of secondary hyperparathyroidism was not found during the follow-up period. Baseline information, abdominal aortic calcification score (AACS), and serum calcium, phosphate, serum alkaline phosphatase (ALP), iPTH and bone metabolism markers were recruited before PTX and after PTX for 6 and 12 months. Results A total of 12 MHD patients after PTX (4 males and 8 females, 51.33 ±13.28 years of age, and 138.58±57.61 months of dialysis vintage) were enrolled in this study. There was no significant difference in AACS between baseline and after PTX for 6 and 12 months (χ2=1.529,P=0.465). Adequate calcium supplement after PTX resulted
    in no significant difference in serum calcium between baseline and after PTX for 6 months. However, serum calcium was significantly lower after PTX for 12 months as compared to that of baseline (P=0.003). Serum phosphate levels after PTX for 6 and 12 months were significantly lower than the baseline value (P=0.043). ALP after PTX for 12 months was significantly lower than that of baseline (P=0.003). iPTH levels after PTX for 6 and 12 months were also significantly lower than the baseline value (P<0.001 and P=0.003 respectively). For serum bone metabolism markers, TRACP, CTX and BAP decreased significantly after PTX for 6 months (P=0.013, P<0.001 and P=0.002 respectively) and 12 months (P<0.001, P=0.001 and P<0.001 respectively); P1NP and N-MID-OC after PTX for 6 months were lower than those of baseline but without statistical significance (P=0.124 and 0.307 respectively). P1NP and N-MID-OC after PTX for 12 months were significantly lower those of baseline (P<0.001 and P=0.003 respectively). Conclusion PTX can improve the disorders of calcium, phosphate and ALP as well as bone metabolism, decrease the rate of bone metabolism turnover, and prevent the progression of cardiovascular calcification. However, PTX may not ameliorate the existed cardiovascular calcification.
    Metrics
    Effect of calcitriol combined with cinacalcet for the treatment of secondary hyperparathyroidism in maintenance hemodialysis patients
    2019, 18 (01):  8-10.  doi: 10.3969/j.issn.1671-4091.2019.01.002
    Abstract ( 483 )   PDF (412KB) ( 811 )  
    【Abstract】Objective To investigate the effect of calcitriol combined with cinacalcet for the treatment of secondary hyperparathyroidism (SHPT) in maintenance hemodialysis (MHD) patients. Methods Thirty patients after MHD treatment for more than three months and with SHPT in our hemodialysis center from May 2012 to August 2017 were enrolled in this study. They were treated with calcitriol (0.25 μg/d) and cinacalcet (25~75 mg/d). Serum calcium, phosphorus, calcium- phosphorus product and intact parathyroid hormone (iPTH) were assayed after the treatment for 1, 3, and 6 months. Adverse reactions due to the drugs were recorded. Results Compared the values after the treatment for 1, 3 and 6 months with those at baseline, serum iPTH, serum phosphorus and calcium and phosphorus product decreased significantly (t=13.457, 25.614 and 49.587 respectively, P<0.001 for serum iPTH; t=3.059, 6.602 and 8.375 respectively, P<0.001 for serum phosphorus; t=3.459, 3.897 and 4.873 respectively, P<0.001 for calcium and phosphorus product), and
    serum calcium increased significantly (t=3.545, 4.012 and 5.104 respectively, P<0.001). Compared the values after the treatment for 3 and 6 months with those after the treatment for one month, serum iPTH, serum phosphorus and calcium and phosphorus product decreased significantly (t=19.579 and 23.675 respectively, P<0.001 for serum iPTH; t=5.309 and 7.214 respectively, P<0.001 for serum phosphorus; t=3.012 and 4.015 respectively, P<0.001 for calcium and phosphorus product), but serum calcium had no significant changes (t=0.905 and 1.105 respectively, P=0.374 and 0.301 respectively). Compared the values after the treatment for 6 months with those after the treatment for 3 months, serum iPTH decreased further (t=14.312, P<0.001), and serum calcium had no significant difference (t=1.397, P=0.205). Nausea and vomiting occurred in 5 cases, abdominal pain in one case, and myalgia in one case. These side-effects improved after reducing the dosage or changing the time of taking medicine. No termination of the treatment due to side-effects happened.
    Conclusion Calcitriol combined with cinacalcet can effectively inhibit the secretion of iPTH and improve the metabolic disorders of calcium and phosphorus with minor adverse reactions. The curative effect is safe and reliable. It is worthy of clinical use.
    Metrics
    Use of Kt instead of Kt/V as a marker of dialysis dose
    2019, 18 (01):  11-15.  doi: 10.3969/j.issn.1671-4091.2019.01.003
    Abstract ( 361 )   PDF (507KB) ( 746 )  
    【Abstract】Objective The aim of this study was to compare the advantage of Kt versus Kt/V as a marker for dialysis dose. Methods We recruited the data of maintenance hemodialysis patients treated in the Dialysis Center of Tong Ren Hospital from January 2017 to July 2017. Target Kt was calculated by the formula of: target Kt =1/[0.0069+(0.0237/BSA(cm)], where BSA is the abbreviation of body surface area. V value was calculated by Watson, HW and Chertow formulas. Receiver Operating Characteristic (ROC) curve was used to analyze the consistency of Kt with Kt/V and URR. SPSS v.22 was used to conduct the analyses. Results In the 103 patients, 65 were males and 38 were females. ROC curve was used for the consistency of Kt with Kt/V (AUC 0.826, 0.797 and 0.700; P<0.001, P<0.001 and P=0.001) and URR (AUC 0.881, 0.734, 0.724; P<0.001). The AUC of Watson method for both Kt/V and URR was the biggest. In the 103 patients, 69% reached the Kt/V but only 44.7% reached the Kt. There were significant differences in body weight (Z=- 2.658, P=0.008), BSA (Z=-2.822, P=0,005), sex (χ2=4.4543, P=0.035), indwelling catheterization (χ2=4.612, P=0.032) between the patients who reached both Kt/V and Kt and the patients who reached Kt/V but not Kt. Conclusions The advantage of monitoring Kt instead of Kt/V is the identification of the patients who did not reach the minimum Kt but satisfied Kt/V value, especially in those with heavier body weight, larger BSA, male sex and catheters in deep vein.
    Metrics
    Effect of goal-directed continuous renal replacement therapy (GD-CRRT) on the prognosis of patient with type 1 cardiorenal syndrome
    2019, 18 (01):  16-20.  doi: 10.3969/j.issn.1671-4091.2019.01.004
    Abstract ( 319 )   PDF (424KB) ( 650 )  
    【Abstract】Objectives To evaluate the effect of goal- directed continuous renal replacement therapy (GD-CRRT) and continuous renal replacement therapy (CRRT) on the prognosis of patient with type 1 cardiorenal syndrome (CRS). Methods A total of 33 cases with type 1 CRS admitted to Beijing Anzhen Hospital
    from January 2015 to December 2017 and treated with GD-CRRT were enrolled in the present study. Thirtythree type 1 CRS cases admitted from January 2010 to December 2017 receiving regular CRRT were selected as matched control. Prognosis including mortality rate and hemodialysis withdrawal or hemodialysis dependence was analyzed and compared between the two groups. Results In GD-CRRT group, the initiation of GD-CRRT was 15.0 h (10.0, 22.5 h) after diagnosis of CRS; the incidence of hypotension was 27.3% (9/33); the application of vasoactive drugs was 21.2% (7/33); the in-hospital mortality, rate of hemodialysis withdrawal and rate of hemodialysis dependence were 18.2% (6/33), 63.6% (21/33) and 18.2% (6/33), respectively. In matched control of CRRT group, the initiation of CRRT was 94.0h (43.5, 183.5 h) after diagnosis of CRS; the incidence of hypotension was 57.6% (19/33); the application of vasoactive drugs was 54.5% (18/33); the inhospital mortality, rate of hemodialysis withdrawal and rate of hemodialysis dependence were 45.4% (15/33),
    27.3% (9/33) and 27.3% (9/33), respectively. There were significant differences in time interval between CRS diagnosis and treatment (Z=-6.989, P<0.001), incidence of hypotension (F=6.203, P=0.013), use of vasoactive agents (F=7.791, P=0.013), in-hospital mortality (F=5.657, P=0.017) and rate of hemodialysis withdrawal (F=8.800, P=0.003) between GD-CRRT group and CRRT group (P<0.05). Multivariate logistic stepwise regression analyses showed that the time interval between CRS diagnosis and treatment (OR=15.15, 95% CI 1.15~200.00, P=0.039), ultrafiltration per unit time (OR=47.13, 95%CI 2.48~893.90, P=0.010) and incidence of hypotension (OR=83.16, 95%CI 5.47~1278.40, P=0.001) were the independent risk factors for death and hemodialysis dependence. Conclusions Patients with type 1 CRS who were treated with early CRRT, accurate volume assessment and dynamic monitoring can effectively maintain the stability of hemodynamics, improve cardiorenal functions and reduce mortality.
    Metrics
    Effects of low calcium dialysate on calcium-phosphorus metabolism and parathyroid hormone level in maintenance hemodialysis patients: a meta- analysis
    2019, 18 (01):  21-25.  doi: 10.3969/j.issn.1671-4091.2019.01.005
    Abstract ( 234 )   PDF (2013KB) ( 630 )  
    【Abstract】Objective To study the application of low calcium dialysate (1.25 mmol/L) in maintenance hemodialysis (MHD) patients and survey its clinical effects on serum calcium (Ca), phosphate (P) and intact parathyroid hormone (iPTH). Methods By search of publications in the last 10 years in CNKI, Wanfang China Science Periodical Database (CSPD), VIP China Science and Technology Journal Database (CSTJ), SinoMed database and PubMed database, a meta-analysis was performed using the publications about the clinical application of low calcium dialysate in MHD patients, and the levels of serum calcium, phosphate and iPTH were then compared between MHD patients using low calcium dialysate (LCD) and calcium 1.5 mmol/L dialysate (HCD). Results Eleven publications were included in the meta-analysis. Serum Ca level in patients using LCD was lower than that in those using HCD (SMD=-0.679, 95% CI -1.157~-0.202, P=0.005). Serum P had no significantly difference between patients using LCD and those using HCD (SMD=-0.824,
    95% CI -1.733~0.085, P=0.076). iPTH level was significant higher in patients using LCD than in those using HCD (SMD=1.235, 95% CI 0.555~1.915, P<0.001). Conclusion LCD can decrease the levels of serum Ca and P and increase the level of iPTH, while HCD can increase the level of serum Ca, decrease the level of serum P, and have no significant effect on iPTH. These two kinds of dialysate have similar effect on the decrease of serum P.
    Metrics
    The influence factors on the effect of plasma exchange in the treatment of patients with acute Guillain- Barré syndrome
    2019, 18 (01):  26-29.  doi: 10.3969/j.issn.1671-4091.2019.01.006
    Abstract ( 288 )   PDF (399KB) ( 661 )  
    【Abstract】Objective To analyze the influence factors on the effect of plasma exchange (PE) in the treatment of patients with acute Guillain- Barré syndrome (GBS). Methods A total of 118 acute GBS patients were divided into PE group and non- PE group. Therapeutic effect was compared between the two groups and the influence factors affecting the PE effect were investigated. Results Fifty GBS patients in PE group were responsive to PE with the effective rate of 73.5%, while 27 GBS patients in non-PE group were responsive with the effective rate of 54% (P=0.023). Multivariate analyses revealed that the number of PE (odds ratio 2.123) and axonal damage (odds ratio 4.758) were the two independent influence factors for the therapeutic effect of PE in the treatment of acute GBS patients. Conclusion PE is an effective treatment for acute GBS. The number of PE and the axonal damage are the two independent influence factors for the therapeutic effect of PE in the treatment of acute GBS patients. Further study is required to validate the findings of this study.
    Metrics
    Barriers to exercise rehabilitation in hemodialysis centers: a cross-sectional survey
    2019, 18 (01):  30-34.  doi: 10.3969/j.issn.1671-4091.2019.01.007
    Abstract ( 307 )   PDF (508KB) ( 596 )  
    【Abstract】Objectives To explore the motivators and barriers to exercise rehabilitation in maintenance hemodialysis (MHD) patients. Methods We recruited patients treated with hemodialysis for more than 3months from 5 dialysis centers in Beijing, and explored the perceived motivators and barriers to exercise rehabilitation by questionnaire in these patients as well as in medical workers for MHD patients. Results A total of 471 MHD patients (277 males and 194 females, 61.3±13.5 years of age) were recruited, and 63.3% of the patients were willing to participate in exercise rehabilitation. The perceived motivators included to improve the quality of life (98.0%), to become healthier (98.0%), and to improve physical functions (95.3%). The perceived barriers included not feeling so well (59.0%), worrying about safety (36.7%), and no interest to join in (27.0%). Ninety medical workers participated in the survey, and the most common barriers were lack of rehabilitation therapists to provide professional guidance and advice (93.1%), insufficient knowledge about exercise rehabilitation (86.2%), and no suitable exercise equipments (P<0.01). Conclusion There were obstacles from patients and medical workers to implement exercise rehabilitation to help MHD patients in dialysis centers. Barriers from MHD patients mainly included not feeling well, safety consideration and lack of interest; barriers from staff included lack of knowledge about rehabilitation, rehabilitation equipment and professional guidance and advice from rehabilitation therapists. Therefore, staff in dialysis center should focus on the rehabilitation status of MHD patients, actively encourage MHD patients to participate in renal rehabilitation, and create a better environment to counter barriers, and promote more patients to participate in rehabilitation to improve
    the quality of life of MHD patients.
    Metrics
    Uremic serum regulates the phenotype transformation of vascular smooth muscle cells through activating the Notch signaling pathway
    2019, 18 (01):  35-41.  doi: 10.3969/j.issn.1671-4091.2019.01.008
    Abstract ( 318 )   PDF (1109KB) ( 560 )  
    【Abstract】Objective To study the effect of uremic serum on phenotype transformation of vascular smooth muscle cells and to correlate the results to the mechanism of arteriovenous fistula (AVF) stenosis and dysfunction. Methods ①The intimal thickness of AVF was compared with normal vessles by elastic Van Gieson staining, and the expressions of α-SMA, FSP-1 and PCNA were evaluated by immunohistochemical staining. ②Human aortic smooth muscle cells (HASMCs) were cultured in vitro and divided into 3 groups: serum-free group (Ctrl group), 10% normal serum group (NS group), and 5~20% uremia serum group (US group). The expressions of α-SMA, SM22α, FSP-1 and PCNA proteins and mRNAs were assessed by Western blot and quantitative PCR. ③The expression of N1ICD protein in different groups was assayed by Western blot; the expressions of Notch1-3, Hes1 and Hes5 mRNAs were detected by quantitative PCR. HASMCs were pre-treated with the Notch signal inhibitor DAPT for 24h, and then the expressions of SM22α, SMMHC, FSP-1, PCNA and Hes1 mRNAs were measured by quantitative PCR. ④The expression of Jagged1, a ligand of Notch, was detected by immunohistochemical staining. Jagged1 protein expressed by human umbilical vein endothelial cells (HUVECs) was assayed by ELISA; Jagged1 expression in HASMCs was measured by Western blot. Results ①In AVF, intimal thickness increased significantly, the expression of α-SMA in neointima was positive, and the positive rates of FSP-1 and PCNA were higher than those in normal vascular tissue (P<0.05). ②In US groups, the expressions of α-SMA and SM22α proteins decreased significantly (P=0.002 and 0.001, respectively), while the expressions of FSP- 1 and PCNA proteins increased significantly (P=0.001 and <0.001, respectively), as compared with those in NS group. These changes showed a tendency of uremia serum concentration dependence. In US group, the expressions of SM22α and SMMHC mRNAs decreased significantly (P=0.014 and 0.003, respectively), while the expressions of FSP-1 and PCNA mRNAs increased significantly (P=0.045 and 0.001, respectively). ③In US group, the expression of N1ICD protein increased significantly (P<0.001), the expressions of Notch1, Notch3, Hes1 and Hes5 mRNAs increased significantly (P<0.001, 0.025, <0.001 and 0.035, respectively), and Notch2 mRNA had no significant difference (P=0.907), as compared with those in NS group. Pre-treatment of DAPT up-regulated the expressions of SM22α and SMMHC mRNAs (P=0.003 and 0.020, respectively) and down-regulated the expressions of FSP-1, PCNA and Hes1 mRNAs (P=0.036, 0.009 and <0.001, respectively). ④In AVF, the expression of Jagged1 increased mainly in neointima. In US group, the expression of Jagged1 protein in HASMCs and HUVECs increased significantly (P=0.001 and 0.005, respectively), as compared with those in NS group. Conclusion Uremic serum promoted the phenotype transformation of vascular smooth muscle cells from deflating type to proliferation type through the up-regulation of Notch ligand Jagged1 and then activation of Notch signaling
    pathway, probably being the mechanism of neointimal hyperplasia in AVF in uremic patients.
    Metrics
    Prediction of cognitive impairment in hemodialysis patients
    2019, 18 (01):  42-45.  doi: 10.3969/j.issn.1671-4091.2019.01.009
    Abstract ( 220 )   PDF (638KB) ( 696 )  
    【Abstract】Objective To analyze the influencing factors for cognitive function in hemodialysis patients and to establish a predictive model. Methods Montreal cognitive assessment (MoCA) and Pittsburgh sleep quality index (PSQI) were used to assess cognitive function and sleep status in 147 hemodialysis patients who were randomly selected from our center. Results Multivariate logistic regression analysis showed that older age (OR=2.29, P=0.047), lower educational level (OR=6.69, P<0.001), poor sleep quality (OR=4.01, P=0.001) were the risk factors for cognitive impairment. The area under the receiver operating characteristic curve (AUC) for nomogram predictive model was 0.77. Conclusion Cognitive impairment is common in hemodialysis patients. Older age, lower educational level and poor sleep quality were the independent risk factors for cognitive impairment. Nomogram can accurately predict the risk of cognitive impairment in hemodialysis patients.
    Metrics
    Prevalence and research progress in the risk factors for end- stage renal disease patients complicated with tuberculosis
    2019, 18 (01):  46-49.  doi: 10.3969/j.issn.1671-4091.2019.01.010
    Abstract ( 286 )   PDF (365KB) ( 636 )  
    【Abstract】End-stage renal disease (ESRD) is one of the emerging burdens of non-communicable disease and the number of ESRD patients is growing rapidly. The prevalence of tuberculosis (TB) is higher among ESRD patients. Diagnosis and treatment of TB are improved with the development of health care system. According to the statistics from World Health Organization, the incidence and mortality of TB are falling. However, we still have to pay more attention to the prevalence of TB among ESRD patients. The coexistence of TB and ESRD is characterized by atypical symptoms and signs, easily leading to misdiagnosis or loss of diagnosis. In addition, ESRD patients with TB have the high risks of side effects to anti-tuberculosis drugs and poor prognosis. This review mainly focuses on the epidemiological characteristics and risk factors for TB in ESRD patients in order to enhance the awareness and to improve the prevention and treatment of TB in ESRD patients.
    Metrics
    Progress in the research of cardiac function test for preoperative assessment of vascular access in patients with chronic kidney disease
    2019, 18 (01):  50-53.  doi: 10.3969/j.issn.1671-4091.2019.01.011
    Abstract ( 320 )   PDF (381KB) ( 604 )  
    【Abstract】Hemodialysis vascular access is a life line for hemodialysis patients with end-stage renal disease. Patients with chronic kidney disease are often associated with various degrees of cardiovascular disease, which increases the perioperative risk of vascular access surgery and affects long- term outcomes. Cardiac function and its reserved capacity should be evaluated in detail before vascular access surgery. To provide references for clinical treatment, appropriate vascular access strategy should be selected according to the comprehensive situations of the patients. The research progress about this issue is summarized in this review.
    Metrics
    Clinical application of the water balloon expansion without incision method to remove the cuff and tunneled catheters in hemodialysis patients
    2019, 18 (01):  57-59.  doi: 10.3969/j.issn.1671-4091.2019.01.013
    Abstract ( 419 )   PDF (378KB) ( 638 )  
    【Abstract】Objective To explore the methods, complications and effects of the water balloon expansion without incision method to remove the cuff and tunneled catheters in hemodialysis patients. Methods During the period between Jan. 2015 and Dec. 2015, 34 hemodialysis patients used the water balloon expansion without incision method (WG group) and 24 hemodialysis patients used the traditional open surgery (TG group) to remove the central vein cuff and tunneled catheters which had the indication to be removed. Results There were no statistically significant differences in gender, age and catheter retention time between the two groups (P=0.897, 0.690 and 0.689 respectively; P>0.05). In TG group, the average operation time was 20.63±7.05 minutes with blood loss of 10.18±4.16 ml; in WG group, the average operation time was 5.44±2.65min with blood loss of 4.04±2.46 ml (P=0.0001 and 0.0001 respectively). Blood leakage and hematoma rate was 2.94% (1/34) in WG group and 12.5% (3/24) in TG group (P=0.374). No infection occurred within two weeks after operation. Conclusion The water balloon expansion without incision method is effective to resolve the difficulties of catheter removal with less operation time and intra-operative bleeding.
    Metrics
    Nationwide investigation on the dialysis center staff to understand and practice the“Water for Hemodialysis and Related Therapies”YY0572-2015
    2019, 18 (01):  65-68.  doi: 10.3969/j.issn.1671-4091.2019.01.016
    Abstract ( 278 )   PDF (461KB) ( 598 )  
    【Abstract】Objective To nationwide investigate the dialysis center staff to understand and practice the “Water for Hemodialysis and Related Therapies” YY0572-2015, and to find out their shortages in the cognition and performance of this standard. Methods Questionnaires were distributed by the China Hospital Association. Data were collected by the WeChat plateform and analyzed by MS Excel. Results The correct cognition rates of bacteria and endotoxin were 87% and 75% respectively. In the investigation for performance, the percentages of total bacterial count and endotoxin test result below the intervention levels were 58.7% and 66.2% respectively; 76% of the dialysis center monitored total chlorine content. Conclusion The cognition and performance of this standard are insufficient in dialysis center staff nationwide. Training of professional staff should be strengthened especially for the full-time technicians. The operation processes should also be standardized to ensure the safety of dialysis patients.
    Metrics